UNIVERSITY OF WASHINGTON
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Antihypertensive Drug/Gene Interactions and CV Events
Completed
- Conditions
- Cardiovascular DiseasesHypertensionHeart DiseasesMyocardial InfarctionCerebrovascular Accident
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2018-05-07
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00005332
Genetics of the Metabolic Syndrome in Japanese Americans
Completed
- Conditions
- Coronary DiseaseHeart DiseasesInsulin ResistanceMetabolic Syndrome XCardiovascular DiseasesDiabetes Mellitus, Non-insulin DependentDiabetes Mellitus
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00005374
Dietary Treatment of Hyperlipidemia in Women vs. Men
Completed
- Conditions
- Heart DiseasesHypercholesterolemiaCardiovascular Diseases
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00005336
Magnesium Sulfate For Brain Injury
Phase 3
Completed
- Conditions
- Brain InjuriesHead InjuryBrain Concussion
- First Posted Date
- 2000-02-28
- Last Posted Date
- 2011-10-28
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00004730
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Tailored Treatments of Fibromyalgia
Phase 2
Completed
- Conditions
- Fibromyalgia
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 312
- Registration Number
- NCT00000422
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances
- First Posted Date
- 1999-11-03
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00000380
HDL-Atherosclerosis Treatment Study (HATS)
Phase 3
Completed
- Conditions
- Coronary DiseaseCardiovascular DiseasesHeart DiseasesMyocardial Ischemia
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00000553
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
Phase 3
Completed
- Conditions
- ArrhythmiaCardiovascular DiseasesHeart ArrestHeart DiseasesMyocardial InfarctionVentricular Fibrillation
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2013-07-29
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00000464
Intravenous Streptokinase in Acute Myocardial Infarction
Phase 3
Completed
- Conditions
- Cardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial InfarctionMyocardial Ischemia
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00000507
Myocardial Infarction Triage and Intervention Project (MITI)
Phase 3
Completed
- Conditions
- Heart DiseasesCardiovascular DiseasesCoronary DiseaseMyocardial InfarctionMyocardial Ischemia
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2016-02-09
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00000468
© Copyright 2025. All Rights Reserved by MedPath